Live Breaking News & Updates on Prnewswire Aptabio

Stay updated with breaking news from Prnewswire aptabio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aptabio to present results of Isuzinaxib Phase 2 study at The American Society of Nephrology (ASN)'s Kidney Week 2022

Aptabio s Isuzinaxib (APX-115) proves its effect on a key kidney function marker in a Phase 2 clinical study in patients with diabetes and chronic kidney. ....

United States , South Korea , Prnewswire Aptabio , Hyesung Shin , Dae Ryong Cha , Centers For Disease , Korea University College Of Medicine , Human Services , Drug Development Company , Platform Technology , Aptabio Therapeutics Inc , American Society Of Nephrology , Us Department Of Health , Urine Albumin Creatine Ratio , Isuzinaxib Phase , American Society , Kidney Week , High Impact Clinical Trials , Patients With Type , Double Blind , Placebo Controlled Phase , Kidney Disease , Kidney Injury , Korea University College , Aptabio Therapeutics , Reactive Oxygen Species ,